Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens don't help with COVID-19 and aren't recommended.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Treating H. pylori infection might help cure alopecia areata.

Higher doses of isotretinoin may lead to more hair loss.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Diet and nutrients, including lycopene from tomatoes and hydroquinone from wheat, can help control melasma, a skin condition.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Avemar may help in cancer treatment, but its effectiveness isn't proven yet.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Perifollicular elastolysis is poorly understood, with limited treatment options and inconsistent results.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

People with androgenetic alopecia often experience more anxiety, depression, and lower self-esteem.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Skin cancer is common in elderly nursing home residents, with risk factors including being male, having light skin, outdoor work history, and smoking. Regular skin checks are recommended.

Tai Chi and Wuqinxi, combined with medication, effectively lower blood pressure.

Platelet-rich plasma, microneedling with minoxidil, and topical finasteride are promising treatments for hair loss.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

No single treatment is clearly effective for central serous chorioretinopathy.

PFAS exposure in adolescence may delay puberty in females.